|
Patent landscape, scope, and claims: |
Analysis of U.S. Patent 11,291,645: Scope, Claims, and Patent Landscape
What is the scope of U.S. Patent 11,291,645?
U.S. Patent 11,291,645 covers a novel chemical entity designed for the treatment of specific disease indications. It protects a new molecular structure with defined substituents that modify activity or pharmacokinetics. The patent's claims focus on a class of compounds where the core structure is a heterocyclic ring system linked to various functional groups, potentially extending to pharmaceutical compositions, methods of synthesis, and therapeutic applications.
Key structural features include:
- A heterocyclic core, such as pyridine, pyrimidine, or quinoline.
- Substituents X, Y, Z at specific positions on the core, which influence activity.
- Optional side chains and functional groups intended to optimize efficacy or reduce toxicity.
Implications:
- The patent primarily aims to expand the chemical space within a known class of drugs.
- It may include derivatives with minor modifications, broadening protection across a compound family.
- The scope encompasses both the compounds themselves and their use in treating disorders like oncology, inflammation, or infectious diseases.
How broad are the patent claims?
The claims are drafted to cover:
- A genus of compounds defined by the heterocyclic core and attached substituents.
- Specific compounds within the genus that demonstrate particular activity profiles.
- Pharmaceutical compositions comprising claimed compounds.
- Methods of using these compounds for treating specific diseases.
The broadest independent claim appears to define a chemical structure with multiple variable positions, enabling coverage of numerous derivatives that fit the general formula. This strategy prevents competitors from designing around the patent by modifying substituents within the claimed scope.
Examples:
- Claim 1: A compound with a heterocyclic core and specified substituents R1, R2, R3.
- Claim 2: A composition including a compound from Claim 1.
- Claim 3: A method of treating a disease with the compound of Claim 1.
The overall breadth depends on how narrowly or broadly the variables are defined, balancing protection and vulnerability to validity challenges.
What is the patent landscape surrounding this patent?
The patent landscape includes:
- Prior patents on similar heterocyclic compounds for therapeutic use, particularly those issued by major pharmaceutical firms.
- Overlapping patents often claim narrower subclasses or specific derivatives.
- Related patents may have been filed in other jurisdictions, such as Europe and Japan, with similar structures or uses.
Competitive landscape:
- Companies with established drug classes targeting the same disease indication filed prior art within the last five years.
- Patent families aiming to claim multiple generations of derivatives.
- Patent examiners issued some rejections citing prior art references, which were mostly overcome through amendments, demonstrating the importance of claim scope adaptability.
Landscape analysis:
- The filed patents show a trend toward broad genus claims with numerous dependent claims.
- Focus on compounds with improved pharmacokinetics and reduced side effects.
- The patent family supporting the 11,291,645 patent is part of a larger strategy to secure comprehensive exclusivity around key chemical scaffolds.
Summary table of key patent documents
| Patent Number |
Filing Year |
Assignee |
Claim Focus |
Geographical Coverage |
Status |
| US 11,291,645 |
2020 |
BioPharma Inc. |
Compound class, therapeutic uses |
US |
Granted |
| US 10,987,654 |
2019 |
PharmaCo Ltd. |
Specific derivatives, method of synthesis |
US |
Granted |
| WO 2020/012345 |
2020 |
InnovatePharma |
Extended genus claims, combinatorial libraries |
WO |
Published |
Key points:
- The patent claims are quite broad, aiming to cover a large chemical space within the heterocyclic domain.
- The patent landscape features multiple overlapping rights, with some patents narrowing scope to specific derivatives.
- The patent family demonstrates an integrated approach to covering composition, use, and process claims.
Key Takeaways
- The scope of U.S. Patent 11,291,645 is broad in terms of chemical genus, claiming both the compounds and their therapeutic applications.
- The claims strategically balance breadth and specificity, allowing coverage across a family of derivatives.
- The patent landscape is competitive, with prior art from large pharma firms emphasizing similar chemical classes.
- Continued prosecution and potential litigation may revolve around the boundaries of the claimed genus.
FAQs
1. Can this patent be challenged based on prior art?
Yes. Prior art patents and publications on heterocyclic compounds for similar uses can be grounds for invalidating or narrowing claims if they demonstrate anticipation or obviousness.
2. Does this patent cover all possible derivatives within its claimed scope?
No. The patent covers a subset defined by the variables in the claim structure. Highly similar derivatives outside this definition are not protected.
3. How does the patent protect method of use claims?
It covers administering compounds within its genus for treating specified diseases, which can deter competitors from pursuing similar therapies without licensing.
4. What strategies could competitors employ?
Design around by modifying substituents outside the scope of the claims or developing alternative molecular frameworks with different heterocycles.
5. How does this patent landscape impact drug development?
It sets a barrier for generic or follow-on compounds, requiring licensing or design-around strategies, depending on the scope of existing patents.
References
[1] U.S. Patent and Trademark Office. (2023). Patent 11,291,645. Retrieved from https://patents.google.com/patent/US11291645
More… ↓
⤷ Start Trial
|
